本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Medibio Ltd

0.001
0.000
成交量:- -
成交額:- -
市值:610.10萬
市盈率:-1.00
高:0.001
開:0.001
低:0.001
收:0.001
52周最高:0.001
52周最低:0.001
股本:61.01億
流通股本:53.23億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.001
每股收益(LYR):-0.001
淨資產收益率:-45.66%
總資產收益率:-13.16%
市淨率:0.96
市盈率(LYR):-1.16

資料載入中...

公司資料

公司名字:
Medibio Ltd
交易所:
ASX
成立時間:
- -
員工人數:
- -
公司地址:
- -
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Medibio Limited, a health technology company, engages in the development of diagnostic systems for mental health illnesses in Australia and the United States. It is involved in the research, development, and commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. Medibio Limited has a research agreement with the Department of Biomedical Sciences of Humanitas University for the development of mental health software products. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was founded in 1998 and is headquartered in Savage, Minnesota.